3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neuroblastoma
1
Neoplasms by Site
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Human Papillomavirus DNA Tests
4
Colposcopy
4
Watchful Waiting
3
Biopsy
3
Acetic Acid
3
Transurethral Resection of Prostate
2
Restraint, Physical
2
Conization
2
Blood Specimen Collection
2
pembrolizumab
1
human papillomavirus vaccine, L1 type 16, 18
1
fludarabine phosphate
1
fludarabine
1
epigallocatechin gallate
1
artesunic acid
1
artemisinin
1
aldesleukin
1
Vaccines
1
Ultrasonography, Doppler
1
Transdermal Patch
1
Respiratory Function Tests
1
Prochlorperazine
1
Pregnancy Tests
1
Positron-Emission Tomography
1
Papanicolaou Test
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nicotine Replacement Therapy
1
Mutagenesis, Insertional
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Pregnancy Tests
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled